mTORC1-TFEB/TFE3 signaling is associated with bile acid diversification during hepatic metabolic adaptation
What this study shows
Establishes a new mTORC1-TFEB/TFE3 signaling axis controlling hepatic bile acid metabolism. Depending on mTORC1 signaling state, mice show coordinated shifts in bile-acid species (non-12-OH vs 12-OH) via altered enzyme expression and cholesterol trafficking; these shifts are reversed by mTORC1 pathway deletion or rapamycin treatment. Dietary protein restriction (which inhibits mTORC1) produces a similar bile-acid shift in mice and correlates with improved metabolic outcomes in human MASLD patients, linking mTORC1 nutrient sensing directly to bile-acid homeostasis and fatty liver disease.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Mouse (liver-specific genetic mTORC1/TFEB manipulation, rapamycin treatment, dietary protein restriction); correlative human MASLD patient cohort); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Mouse (liver-specific genetic mTORC1/TFEB manipulation, rapamycin treatment, dietary protein restriction); correlative human MASLD patient cohort |
| Journal | Science Advances |
| Year | 2026 |
| Peer reviewed | Yes |
| Record last updated | 2026-09-23 |
| Source | DOI 10.1126/sciadv.aee1905 · PMID 42789715 |